Free 7-day Trial
All Articles and Columns »

Weekly Guru Bargains Highlights: MetroPCS Communications Inc, Isis Pharmaceuticals Inc, Leap Wireless International Inc, Universal Health Services Inc, Con-way Inc.

Ben Graham

guruyt

4 followers
Last week’s top five guru bargain stocks were MetroPCS Communications Inc, Isis Pharmaceuticals Inc, Leap Wireless International Inc, Universal Health Services Inc, and Con-way Inc. According to GuruFocus updates, these stocks have declined the most since Gurus have bought.

MetroPCS Communications Inc. (PCS): Down 42% Since Michael Price Bought In the Quarter Ended on 2009-09-30

Michael Price added to his holdings in Mobile Telecommunications company MetroPCS Communications Inc. by 828.57% during the quarter ended 09/30/2009. He owned 325,000 shares of as of 09/30/2009. MetroPCS Communications provides wireless communications services. Metropcs Communications Inc. has a market cap of $2.11 billion; its shares were traded at around $5.99 with a P/E ratio of 11.7 and P/S ratio of 0.8.

MetroPCS recently reported its third quarter results. The company announced that its consolidated total revenue was approximately $896 million, an increase of 30% over third quarter of 2008. “This quarter we focused on managing costs; we delivered solid financial results and positioned the company for future growth. On a consolidated basis, we reported the highest consolidated quarterly Adjusted EBITDA in company history. In a seasonally slow quarter, we reported net additions that were below our expectations, due primarily to elevated churn and a deceleration in gross additions. We believe this was the result of continued U.S. macro-economic weakness, an increasingly competitive environment, and upward adjustments we made to the price of certain handsets,” said Roger D. Linquist, Chairman, President and Chief Executive Officer of MetroPCS.

Richard Perry bought 1,250,000 shares in the quarter that ended on 09/30/2009, which is 1.02% of the $1.15 billion portfolio of Perry Capital. George Soros bought 294,060 shares in the quarter that ended on 09/30/2009, which is 0.06% of the $4.41 billion portfolio of Soros Fund Management LLC. Michael Price owns 325,000 shares as of 09/30/2009, an increase of 828.57% from the previous quarter. This position accounts for 0.9% of the $338 million portfolio of MFP Investors LLC. Wilbur Ross owns 3,322,020 shares as of 09/30/2009, which accounts for 5.14% of the $605 million portfolio of Invesco Private Capital, Inc..

Isis Pharmaceuticals Inc. (ISIS): Down 31% Since Bruce Kovner Bought In the Quarter Ended on 2009-09-30

Bruce Kovner added to his holdings in Biotechnology company Isis Pharmaceuticals Inc. by 30.81% during the quarter ended 09/30/2009. He owned 29,872 shares of as of 09/30/2009. Isis Pharmaceuticals, Inc. is a leading genomics-based drug discovery and development company that is focused on RNA. RNA is a novel target for drug discovery, and Isis has established a dominant position in RNA research. The company has integrated the expertise in molecular and cellular biology, medicinal chemistry, RNA biochemistry, bioinformatics, pharmacology and clinical development to create two exciting technologies, antisense and Ibis, a robust pipeline of drugs in development and genomics services. Isis Pharmaceuticals Inc. has a market cap of $1.09 billion; its shares were traded at around $11.09 with and P/S ratio of 10.1.

Iris Pharmaceuticals recently reported its third quarter 2009 results. The company announced that it had a net loss of $3.4 million, and a net operating loss of $6.9 million. "We are projecting to end 2009 in the strongest financial position in our history, maintaining our momentum of strong financial performance with our second year of profitability. And, we believe that our business model will enable us to sustain a strong financial position beyond this year. In addition to our financial success, we are performing in all other areas of our business. To date, we have reported positive top-line clinical data from our two most advanced programs, Phase 3 data on mipomersen in patients with homozygous familial hypercholesterolemia and most recently Phase 2 data on ISIS 113715 in patients with type 2 diabetes. Further, we and our partners have advanced a number of antisense drugs into development and into the clinic. As we approach the end of 2009, our financial position ensures that we can continue to advance our technology, discover and develop a significant number of promising new drugs, and capitalize on our technology to continue to build our financial strength," said B. Lynne Parshall, COO and CFO of Isis.

Sell:: Chairman, President, CEO Stanley T Crooke sold 6,535 shares of ISIS stock on 12/30/2009 at the average price of 11.07, the price of the stock has increased by 0.18% since. Many other insiders have also decreased their positions in the company.

Leap Wireless International Inc. (LEAP): Down 34% Since George Soros Bought In the Quarter Ended on 2009-09-30

George Soros initiated holdings in Mobile Telecommunications company Leap Wireless International Inc. during the quarter ended 09/30/2009. He owned 74,400 shares of as of 09/30/2009. Leap Wireless is a customer-focused company providing innovative mobile wireless services that are targeted to meet the needs of customers who are under-served by traditional communications companies. Leap Wireless International Inc. has a market cap of $1.1 billion; its shares were traded at around $14.17 with and P/S ratio of 0.6.

George Soros bought 74,400 shares in the quarter that ended on 09/30/2009, which is 0.03% of the $4.41 billion portfolio of Soros Fund Management LLC. Jean-Marie Eveillard owns 542,650 shares as of 09/30/2009, an increase of 19.96% from the previous quarter. This position accounts for 0.1% of the $10.76 billion portfolio of Arnhold & S. Bleichroeder Advisers, LLC.

Lee Ainslie sold out his holdings in the quarter that ended on 09/30/2009.

LEAP Wireless recently reported its third quarter results. The company announced that its service revenues for the third quarter increased 25 percent over the prior year quarter to $541.3 million. It also announced an adjusted OIBDA of $121.5 million for the third quarter, up $24 million over the comparable period of the prior year. For the quarter, adjusted OIBDA for the Company’s existing business was $175.0 million, an increase of $28.1 million from the prior year period. This improvement reflects an approximately 263,000 year-over-year increase in end-of-period customers in existing markets and the resulting benefits of scale. The Company’s operating income for the quarter was $1.4 million, compared to $2.4 million for the third quarter of 2008.ed at around $15.16 with and P/S ratio of 0.5.

Sell:: 10% Owner Sachs Group Inc Goldman sold 85,220 shares of LEAP stock on 10/01/2009 at the average price of 18.3, the price of the stock has decreased by 22.57% since.

Universal Health Services Inc. (UHS): Down 49% Since Westport Asset Management Bought In the Quarter Ended on 2009-09-30

Westport Asset Management added to his holdings in Health Care Providers company Universal Health Services Inc. by 100% during the quarter ended 09/30/2009. He owned 1,005,200 shares of as of 09/30/2009. Universal Health Services Inc. has a market cap of $2.88 billion; its shares were traded at around $29.23 with a P/E ratio of 12.5 and P/S ratio of 0.6. The dividend yield of Universal Health Services Inc. stocks is 0.3%. Universal Health Services Inc. had an annual average earning growth of 11.4% over the past 10 years. GuruFocus rated Universal Health Services Inc. the business predictability rank of 4-star.

UHS recently reported its third quarter results. The company reported that its net income was $51.1 million, or an increase of 41% to $1.03 per diluted share, during the third quarter of 2009 as compared to $37.0 million, or $.73 per diluted share, during the comparable quarter of the prior year. Net revenues increased 4% to $1.30 billion during the third quarter of 2009 as compared to $1.24 billion during the third quarter of 2008. "We are extremely pleased with these solid results in an extremely challenging environment," said Alan B. Miller, Chief Executive Officer. "The continued economic weakness continues to drive higher levels of uncompensated care and pressure certain markets in particular, but the overall balance in our acute portfolio and the very steady performance of our behavioral segment has contributed to another very satisfying performance this quarter."

Edward Owens owns 2,160,400 shares as of 09/30/2009, which accounts for 0.74% of the $18.2 billion portfolio of Vanguard Health Care Fund. Chris Davis owns 157,500 shares as of 09/30/2009, which accounts for 0.02% of the $61.3 billion portfolio of Davis Selected Advisers. Private Capital owns 803,734 shares as of 09/30/2009, which accounts for 3.17% of the $1.57 billion portfolio of Private Capital Management.

Andreas Halvorsen owns 192,300 shares as of 09/30/2009, a decrease of 64.88% of from the previous quarter. This position accounts for 0.15% of the $7.83 billion portfolio of Viking Global Investors LP.

Sell:: Chairman and CEO, 10% Owner Alan B Miller sold 20,000 shares of UHS stock on 12/14/2009 at the average price of 29.97, the price of the stock has decreased by 2.47% since. Other insiders have also decreased their positions in the company.

Con-way Inc. (CNW): Down 26% Since Richard Aster Jr Bought In the Quarter Ended on 2009-09-30

Richard Aster Jr added to his holdings in Trucking company Con-way Inc. by 17.68% during the quarter ended 09/30/2009. He owned 519,900 shares of as of 09/30/2009. Con-way Inc.is a freight transportation and logistics company with businesses in less-than-truckload and full truckload freight services, brokerage, logistics, warehousing, supply chain management and trailer manufacturing. The company has a market cap of $1.49 billion; its shares were traded at around $30.31 with a P/E ratio of 42.7 and P/S ratio of 0.3. The dividend yield of Con-way Inc. stocks is 1.3%. Con-way Inc. had an annual average earning growth of 1.2% over the past 10 years.

Richard Aster Jr owns 519,900 shares as of 09/30/2009, an increase of 17.68% from the previous quarter. This position accounts for 0.88% of the $2.26 billion portfolio of Meridian Fund. HOTCHKIS & WILEY owns 530,704 shares as of 09/30/2009, a decrease of 49.3% of from the previous quarter. This position accounts for 0.14% of the $14.26 billion portfolio of HOTCHKIS & WILEY Capital Management LLC. Richard Pzena sold out his holdings in the quarter that ended on 09/30/2009. Arnold Schneider sold out his holdings in the quarter that ended on 09/30/2009.

Sell:: Director, President & CEO Douglas Stotlar sold 26,500 shares of CNW stock on 08/04/2009 at the average price of 46.04, the price of the stock has decreased by 34.17% since. Other insiders have also decreased their positions in the company.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide